Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) May 22, 2013

 

 

CME GROUP INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-31553   36-4459170

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification No.)

 

20 South Wacker Drive

Chicago, Illinois

  60606
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (312) 930-1000

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

At the close of business on March 27, 2013, the record date of the 2013 Annual Meeting of Shareholders (the “Annual Meeting”) of CME Group Inc. (the “Company”), the Company had 333,881,305 shares of Class A and Class B common stock issued and outstanding. The holders of a total of 279,557,932 shares of Class A and Class B common stock were present at the Annual Meeting, either in person or by proxy, which total constituted approximately 84% of the issued and outstanding shares on the record date for the Annual Meeting.

The results of the proposals are as follows:

 

  1. The election of nine Equity Directors to serve until 2014 (elected by the Class A and Class B shareholders voting together as a single class):

 

Name

   Votes For      Votes Withheld  

Terrence A. Duffy

     237,029,014         9,556,373   

Charles P. Carey

     236,059,798         10,525,589   

Mark E. Cermak

     239,242,256         7,343,131   

Martin J. Gepsman

     236,636,195         9,949,192   

Leo Melamed

     219,482,029         27,103,358   

Joseph Niciforo

     237,386,321         9,199,066   

C.C. Odom II

     239,613,410         6,971,977   

John F. Sandner

     219,584,875         27,000,512   

Dennis A. Suskind

     239,283,103         7,302,284   

There were a total of 32,972,545 broker non-votes in this proposal.

 

  2. The ratification of the appointment of Ernst & Young LLP as the Company’s independent public accounting firm for 2013 (ratified by the Class A and Class B shareholders voting together as a single class):

 

Votes For      Votes Against      Abstentions  
  275,212,262         3,858,229         487,441   

 

  3. The approval, by advisory vote, of the compensation of the Company’s named executive officers (approved by the Class A and Class B shareholders voting together as a single class):

 

Votes For    Votes Against      Abstentions  
238,787,144      6,523,052         1,275,191   

There were a total of 32,972,545 broker non-votes in this proposal.


4. Shareholder Proposal Regarding Proxy Access (failed to receive sufficient support from the Class A and Class B shareholders voting together as a single class):

 

Votes For      Votes Against      Abstentions  
  80,853,219         165,096,818         635,350   

There were a total of 32,972,545 broker non-votes in this proposal.

 

5. The election of Class B Directors:

 

  a. The election of one Class B-1 Director to serve until 2014 from a slate of two nominees (elected by the Class B-1 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

Paul J. Heffernan

     33         59         142   

Howard J. Siegel

     146         20         68   

 

  b. The election of one Class B-3 Director to serve until 2014 from a slate of two nominees (elected by the Class B-3 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

Peter J. Kosanovich

     187         71         247   

Steven E. Wollack

     230         115         160   

 

6. The election of Class B Nominating Committees:

 

  a. The election of five members of the Class B-1 Nominating Committee to serve until 2014 from a slate of ten nominees (elected by the Class B-1 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

William C. Bauman

     91         19         117   

Thomas A. Bentley

     87         26         114   

Michael J. Downs

     101         15         111   

Stephen F. French

     58         25         144   

John C. Garrity

     100         12         115   

Bradley S. Glass

     73         27         127   

Mark S. Kobilca

     32         32         163   

Brian J. Muno

     81         16         130   

Michael J. Small

     48         27         152   

Kenneth G. Zekich

     48         32         147   

 

  b. The election of five members of the Class B-2 Nominating Committee to serve until 2014 from a slate of ten nominees (elected by the Class B-2 shareholders) was deferred to June 11, 2013 at 1:30 p.m. at 20 South Wacker Drive, Chicago, Illinois.


  c. The election of five members of the Class B-3 Nominating Committee to serve until 2014 from a slate of ten nominees (elected by the Class B-3 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

J. Kenny Carlin

     190         42         262   

Bryan P. Cooley

     216         34         244   

Laurence E. Dooley

     119         64         311   

Mario J. Florio

     151         43         300   

Christopher P. Gaffney

     201         29         264   

David P. Gaughan

     97         71         326   

Timothy F. Hendricks

     196         40         258   

Matthew J. Mokszycki

     55         82         357   

Timothy J. Nagy

     130         69         295   

Donald J. Sliter

     117         77         300   


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    CME Group Inc.
    Registrant
Date: May 28, 2013     By:   /s/ Kathleen M. Cronin
    Name:   Kathleen M. Cronin
    Title:  

Senior Managing Director, General

Counsel and Corporate Secretary